London, United Kingdom

Nigel Peter Minton

This inventor holds 1 USPTO granted patent. Top assignee: Public Health Laboratory Service Board. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nigel Peter Minton. Retrieved from https://idiyas.com/inventor/nigel-peter-minton-wymyzaaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nigel Peter Minton

Introduction

Nigel Peter Minton is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address superoxide radicals. His work has implications for the treatment and prevention of various pathological conditions.

Latest Patents

Minton holds a patent for a pharmaceutical composition containing superoxide dismutase. This composition is designed for the prophylaxis or treatment of conditions resulting from superoxide radicals. It includes a manganese-superoxide dismutase (MnSOD) enzyme in its native form, which is free of pyrogens from specific Bacillus species. The patent also outlines processes for producing this novel composition and methods for its application in medical treatments.

Career Highlights

Minton is associated with the Public Health Laboratory Service Board, where he has contributed to research and development in public health. His work focuses on innovative solutions to health challenges, particularly those related to oxidative stress and its effects on human health.

Collaborations

Minton has worked alongside notable colleagues such as Anthony Atkinson and Kevin John Bown. Their collaborative efforts have furthered research in the field of pharmaceutical sciences.

Conclusion

Nigel Peter Minton's contributions to pharmaceutical innovations highlight the importance of addressing oxidative stress in medical treatments. His patent for a manganese-superoxide dismutase composition represents a significant advancement in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…